Current therapeutic strategies in non-alcoholic fatty liver disease.
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease ranging from simple steatosis through steatohepatitis (NASH) to increasing fibrosis and eventual cirrhosis. NAFLD is the hepatic manifestation of the metabolic syndrome and has now become the most common cause of liver disea...
Main Authors: | Dowman, J, Armstrong, M, Tomlinson, J, Newsome, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Pathogenesis of non-alcoholic fatty liver disease.
by: Dowman, J, et al.
Published: (2010) -
The diagnosis of non-alcoholic fatty liver disease: authors' reply
by: Dowman, J, et al.
Published: (2012) -
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2011) -
Glucocorticoids and non-alcoholic fatty liver disease.
by: Woods, C, et al.
Published: (2015) -
Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
by: Yajie Fu, et al.
Published: (2022-11-01)